Lilly has been solidly investing in research and development (R&D) throughout 2024. In April, the company announced the ...

The U.S. Food and Drug Administration (FDA) is rethinking its decision to remove popular weight-loss and diabetes drugs from ...

Weight loss medications such as Ozempic may be able to cut drug and alcohol abuse in half, according to a new study from the ...

The drugmaker's financial results are also impressive, spearheaded by tirzepatide, a therapy for diabetes and obesity that is ...

Founded in 1993, The Motley Fool is a financial services company dedicated to making the world smarter, happier, and richer.

THURSDAY, Oct. 17, 2024 (HealthDay News) -- Weight-loss and diabetes drugs like Ozempic, Wegovy, Mounjaro or Zepbound appear ...

Democrat Wesley Harris and Republican Brad Briner are vying to be the state’s next treasurer, overseeing the management of ...

Weight-loss drugs such as Ozempic, made by Denmark's Novo Nordisk, can reduce rates of opioid and alcohol abuse by up to 50%, according to a new study that supports expectations the drugs can offer ...

You’ve probably heard of the semaglutide brand names Ozempic®, Wegovy, and Rybelsus. You may have even heard about affordable options like compounded semaglutide.

A new study published Thursday found that groundbreaking weight loss and diabetes medications also combat opioid-use disorder and alcohol misuse disorder. This is the second study this fall to suggest ...

The logic suggested by the Lilly trial is the opposite, however. It proposes that being overweight is a primary cause of ...

Not everybody loses the same amount of weight on medications such as Ozempic and Saxenda—treatment indication, dosage, and ...